Document And Entity Information [Abstract] Document And Entity Information [Abstract] Statement [Table] Statement [Table] Statement [Line Items] Statement [Line Items] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Well Known Seasoned Issuer Entity Current Reporting Status Entity Voluntary Filers Entity Filer Category Entity Filer Category Entity Public Float Entity Common Stock Shares Outstanding Entity Common Stock, Shares Outstanding CONSOLIDATED BALANCE SHEETS [Abstract] Assets [Abstract] Assets Assets Current [Abstract] Current assets: Cash And Cash Equivalents At Carrying Value Cash and cash equivalents at end of period Cash and cash equivalents at beginning of period Cash and cash equivalents Accounts Receivable Net Current Trade receivables Inventory Net Inventory Total inventory classified as current Prepaid Expense And Other Assets Current Prepaid expenses and other current assets Assets Current Total current assets Other Inventory Noncurrent Less strategic inventory classified as non-current Strategic inventory Property Plant And Equipment Net Property and equipment, net of accumulated depreciation Property and equipment net Other Assets Noncurrent Other assets Assets Total assets Liabilities And Stockholders Equity [Abstract] Liabilities and stockholders' equity Liabilities Current [Abstract] Current liabilities: Accounts Payable Current Accounts payable Accrued Clinical Expenses Current Accrued Clinical Expenses Current Accrued clinical expenses Accrued Liabilities Current Other accrued liabilities Other accrued liabilities Long Term Debt Current Less current portion Long-term obligation-current portion Deferred Revenue Current Deferred revenue Liabilities Current Total current liabilities Long Term Debt Noncurrent Long-term obligation, net of current portion Commitments And Contingencies Commitments Stockholders Equity [Abstract] Stockholders' equity: Preferred Stock Value Preferred stock, $0.001 par value, 10,000 shares authorized and no shares outstanding at December 31, 2014 or 2013 Common Stock Value Common stock, $0.001 par value, 280,000 shares authorized and 101,395 and 99,849 shares issued and outstanding at December 31, 2014 and 2013, respectively Additional Paid In Capital Additional paid-in capital Retained Earnings Accumulated Deficit Accumulated deficit Stockholders Equity Ending Balance Beginning Balance Total stockholders' equity Liabilities And Stockholders Equity Total liabilities and stockholders' equity Preferred Stock Par Or Stated Value Per Share Preferred stock, par value Preferred Stock Shares Authorized Preferred stock, shares authorized Preferred Stock Shares Outstanding Preferred stock, shares outstanding Common Stock Par Or Stated Value Per Share Common stock, par value Common Stock Shares Authorized Common stock, shares authorized Common Stock Shares Issued Common stock, shares issued Common Stock Shares Outstanding Common stock, shares outstanding CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS [Abstract] Sales Revenue Goods Net Product sales, net Operating Expenses [Abstract] Operating expenses: Cost Of Revenue Cost of sales Research And Development Expense Cost incurred under the agreement Selling General And Administrative Expense Selling, general and administrative Operating Expenses Total operating expenses Operating Income Loss Loss from operations Interest And Debt Expense Interest and other expense Net Income Loss Net loss Net loss and comprehensive loss Earnings Per Share Basic And Diluted Basic and diluted net loss per share Weighted Average Number Of Share Outstanding Basic And Diluted Shares used in computing basic and diluted net loss per share CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY [Abstract] Statement Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Common Stock [Member] Common Stock [Member] Additional Paid In Capital [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Accumulated Deficit [Member] Deferred Compensation Arrangement With Individual Excluding Share Based Payments And Postretirement Benefits By Type Of Deferred Compensation [Axis] Deferred Bonus And Profit Sharing Arrangement Individual Contract Type Of Deferred Compensation [Domain] Type of Deferred Compensation, All Types [Domain] Employees and Directors [Member] Employees And Directors [Member] Employees and Directors [Member] Non-employee [Member] Non Employee [Member] Non-employee [Member] Statement Class Of Stock [Axis] Class Of Stock [Domain] Class of Stock [Domain] Public [Member] Public [Member] Public Financing Transaction [Member] Private Equities [Member] Private Equities [Member] Private Equity Transaction [Member] Shares Outstanding Ending Balance (in shares) Beginning Balance (in shares) Stock Issued During Period Shares New Issues Common stock, shares issued Issuance of stock (in shares) Stock Issued During Period Value New Issues Issuance of stock Stock Issued During Period Shares Warrants Exercised Stock Issued During Period Shares Warrants Exercised Common stock shares issued upon exercise of warrants Issuance of common stock upon exercise of warrants (in shares) Stock Issued During Period Value Warrants Exercised Stock Issued During Period Value Warrants Exercised Issuance of common stock upon exercise of warrants Stock Issued During Period Shares Stock Options Exercised Shares exercised Common shares to be issued upon exercise of options Issuance of common stock upon exercise of options (in shares) Stock Issued During Period Value Stock Options Exercised Issuance of common stock upon exercise of options Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value Stock-based compensation Comprehensive Income Net Of Tax Net loss and comprehensive loss CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract] Operating activities Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operations: Share Based Compensation Stock-based compensation Accretion Expense Accretion of interest expense Amortization Of Financing Costs Amortization of debt financing costs Depreciation Depletion And Amortization Depreciation and amortization of property and equipment Increase Decrease In Operating Capital [Abstract] Changes in operating assets and liabilities: Increase Decrease In Accounts Receivable Trade receivables Increase Decrease In Inventories Inventory Increase Decrease In Prepaid Deferred Expense And Other Assets Prepaid expenses and other current assets Increase Decrease In Other Operating Assets Other assets Increase Decrease In Accounts Payable Accounts payable Increase Decrease In Other Current Liabilities Accrued clinical expenses Increase Decrease In Other Accounts Payable And Accrued Liabilities Other accrued liabilities Increase Decrease In Deferred Revenue Deferred revenue Net Cash Provided By Used In Operating Activities Continuing Operations Net cash used in operating activities Investing activities Payments To Acquire Property Plant And Equipment Purchases of property and equipment Cash used in investing activities Cash used in investing activities Financing activities Proceeds From Issuance Or Sale Of Equity Proceeds from issuance of common stock and warrants, net of issuance costs Proceeds from exercise of stock options, net of issuance costs Proceeds From Debt Net Of Issuance Costs Proceeds from issuance of long-term obligation, net of cash paid for issuance costs Repayments Of Long Term Debt Payments related to long-term obligation Aggregate payments to long-term obligations Net Cash Provided By Used In Financing Activities Continuing Operations Net cash (used in) provided by financing activities Cash And Cash Equivalents Period Increase Decrease Net (decrease) increase in cash and cash equivalents Basis of Presentation and Summary of Significant Accounting Policies [Abstract] Basis Of Presentation And Significant Accounting Policies [Text Block] Basis of Presentation and Summary of Significant Accounting Policies Significant Agreements Disclosure [Abstract] Significant Agreements [Abstract] Commitments Disclosure [Text Block] Significant Agreements Fair Value of Financial Instruments [Abstract] Fair Value Disclosures [Text Block] Fair Value of Financial Instruments Composition of Certain Balance Sheet Items [Abstract] Supplemental Balance Sheet Disclosures [Text Block] Composition of Certain Balance Sheet Items Long-Term Obligation [Abstract] Long Term Debt [Text Block] Long-Term Obligation Lease Obligations [Abstract] Leases Of Lessee Disclosure [Text Block] Lease Obligations Related Party Transactions [Abstract] Related Party Transactions Disclosure [Text Block] Related Party Transactions Preferred Stock and Stockholders' Equity [Abstract] Stockholders Equity Note Disclosure [Text Block] Preferred Stock and Stockholders' Equity Net Loss Per Share [Abstract] Earnings Per Share [Text Block] Net Loss Per Share Income Taxes [Abstract] Income Tax Disclosure [Text Block] Income Taxes Commitments [Abstract] Commitments And Contingencies Disclosure [Text Block] Commitments Quarterly Financial Data [Abstract] Quarterly Financial Information [Text Block] Quarterly Financial Data Business Description Policy Business Description Policy [Text Block] Description of Business Use Of Estimates Use of Estimates Cash And Cash Equivalents Policy [Text Block] Cash and Cash Equivalents Concentration Risk Credit Risk Credit Risks and Concentrations Fair Value Measurement Policy Policy [Text Block] Fair Value Measurements Receivables Policy [Text Block] Trade Receivables Inventory Policy [Text Block] Inventory Property Plant And Equipment Policy [Text Block] Property and Equipment Debt Policy [Text Block] Long-term Obligation Revenue Recognition Revenue Reductions Net Product Sales Cost Of Sales Policy [Text Block] Cost of Sales Research And Development Expense Policy Research and Development Segment Reporting Policy Policy [Text Block] Segment Reporting Share Based Compensation Option And Incentive Plans Policy Stock-Based Compensation Income Tax Policy [Text Block] Income Taxes Recently Issued Accounting Pronouncements Tabular disclosure of the carrying amount as of the balance sheet date of current and non current inventory. Inventory Table [Text Block] Composition of Inventory Property Plant And Equipment [Text Block] Property and Equipment Schedule Of Accrued Liabilities Table [Text Block] Other Accrued Liabilities Schedule Of Debt Table [Text Block] Summary of Payment Obligations under Financing Agreement Schedule Of Stock By Class [Text Block] Shares of Common Stock Reserved for Future Issuance Schedule Of Share Based Compensation Stock Options Activity Table [Text Block] Summary of Stock Plan Activity Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Text Block] Summary of Options Outstanding and Exercisable Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block] Summary of Weighted-Average Assumptions and Resultant Fair Value-Based Measurements for Options Granted to Employees and Directors Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block] Summary of Non-Cash Stock-Based Compensation by Financial Statement Classification Schedule Of Stockholders Equity Note Warrants Or Rights [Text Block] Warrants Outstanding Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block] Securities Outstanding that could Potentially Dilute Per Share Data Schedule Of Deferred Tax Assets And Liabilities Table [Text Block] Significant Components of Deferred Tax Assets Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block] Reconciliation of Statutory Federal Income Tax Rate to Effective Rate Schedule Of Quarterly Financial Information Table [Text Block] Quarterly Financial Data Accounting Policies [Table] Accounting Policies [Table] Accounting Policies [Table] Range [Axis] Range [Member] Range [Domain] Minimum [Member] Minimum [Member] Maximum [Member] Maximum [Member] Major Customers [Axis] Name Of Major Customer [Domain] Customer [Domain] Customer 1 [Member] Customer One [Member] Specialty Pharmacy [Member] Other Commitments [Axis] Other Commitments [Domain] Other Commitments [Domain] Financing Agreement [Member] Financing Agreement [Member] Financing Agreement with Biopharma [Member] Accounting Policies [Line Items] Accounting Policies [Line Items] Accounting Policies [Line Items] Date of incorporation Entity incorporated, State Additional Cash And Cash Equivalent Related Text Additional cash and cash equivalents, description Concentration Risk Percentage 1 Percentage of sales to one specialty pharmacy customers Concentration Risk, Number of Customers Concentration Risk Number Of Customers Number of customers Concentration Risk, Number of Suppliers Concentration Risk Number Of Suppliers Number of manufacturers Property Plant And Equipment Useful Life Property and equipment, estimated useful life Debt Instrument Issuance Date 1 Debt issuance date Proceeds From Issuance Of Debt Proceeds from issuance of long-term obligation, net of cash paid for issuance costs Contractual Obligation Cumulative payments to be made under financing agreement Cumulative payments to be made under financing agreement Accounts Receivable Payment Terms Accounts Receivable Payment Terms Payment terms for discount on sales of Korlym sales Number Of Operating Segments Number of operating segments Share Based Compensation Arrangement Performance Based Probability Percentage Of Achieving For Expense Recognition Share Based Compensation Arrangement Performance Based Probability Percentage Of Achieving For Expense Recognition Probability percentage for achieving performance-based vesting criteria for expense recognition Schedule Of Debt And Credit Agreements [Table] Schedule Of Debt And Credit Agreements [Table] Schedule Of Debt And Credit Agreements [Table] Type Of Arrangement [Axis] Arrangements And Nonarrangement Transactions [Member] Arrangements and Non-arrangement Transactions [Domain] CuraScript specialty pharmacy [Member] Cura Script Specialty Pharmacy [Member] CuraScript Specialty Pharmacy [Member] Centric Health Resources, Inc. [Member] Centric Health Resources Inc [Member] Centric Health Resources, Inc. [Member] Agreement Seven [Member] Agreement Seven [Member] Agreement with PCAS [Member] Agreement One [Member] Agreement One [Member] Agreement with AAI Pharma [Member] Agreement Five [Member] Agreement Five [Member] Ockham Development Group Inc. [Member] Quotient Clinical Limited [Member] Quotient Clinical Limited [Member] Quotient Clinical Limited [Member] Research And Development Arrangement Contract To Perform For Others By Type [Axis] Research And Development Arrangement Contract To Perform For Others Type [Domain] Research and Development Arrangement, Contract to Perform for Others, Type [Domain] License Agreement [Member] License Agreement [Member] Stanford License Agreement [Member] Statement Scenario [Axis] Scenario Unspecified [Domain] Scenario, Unspecified [Domain] Annual Payment [Member] Annual Payment [Member] Annual Payment [Member] Debt And Credit Agreements [Line Items] Debt And Credit Agreements [Line Items] Debt And Credit Agreements [Line Items] Significant Purchase Commitment Description Agreement description Long Term Purchase Commitment Time Period Initial agreement period Automatic Extension Period Automatic Extension Period Automatic extension period Termination Notice Period Termination Notice Period Agreement termination, written notice period Termination Notice Period For Manufacturer Termination Notice Period For Manufacturer Termination notice period for manufacturer Right To Terminate Agreement If Unable To Manufacture Product Period Right To Terminate Agreement If Unable To Manufacture Product Period Right to terminate agreement if unable to manufacture product, period Other Commitments Description Agreement extension notice period Agreement Termination Date Agreement Termination Date Agreement termination date Sales Returns Goods Return reserve for inventory Long Term Purchase Commitment Amount Commitment amount related to service agreement Stock Issued During Period Shares Purchase Of Assets Issuance of common stock in conjunction with a license agreement Royalty Guarantees Commitments Amount Royalty payments to be made Fair Value By Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Fair Value By Fair Value Hierarchy Level [Axis] Fair Value Measurements Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Fair Value Inputs Level1 [Member] Level 1 [Member] Financial Instrument [Axis] Transfers And Servicing Of Financial Instruments Types Of Financial Instruments [Domain] Financial Instruments [Domain] Money Market Funds [Member] Money Market Fund [Member] Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Cash And Cash Equivalents Fair Value Disclosure Money market fund, fair value Inventory Raw Materials Net Of Reserves Raw materials Inventory Work In Process Net Of Reserves Work in progress Inventory Finished Goods Net Of Reserves Finished goods Inventory Current Noncurrent Net Inventory Current Noncurrent Total inventory Supplemental Balance Sheet Information [Table] Supplemental Balance Sheet Information [Table] Supplemental Balance Sheet Information [Table] Property Plant And Equipment By Type [Axis] Property Plant And Equipment Type [Domain] Property, Plant and Equipment, Type [Domain] Furniture And Equipment [Member] Furniture And Equipment [Member] Furniture and Equipment [Member] Vehicles [Member] Vehicles [Member] Computer Software Intangible Asset [Member] Software [Member] Leasehold Improvements [Member] Leasehold Improvements [Member] Other Liabilities [Line Items] Other Liabilities [Line Items] Other Liabilities [Line Items] Property Plant And Equipment Gross Property and equipment Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Less: accumulated depreciation Accrued Vacation Current Accrued compensation Accrued Professional Fees Current Professional fees Accrued Marketing Costs Current Commercialization costs Accrued Government Rebate Current Accrued Government Rebate Current Government rebates Accrued Legal Fees, Current Accrued Legal Fees Current Legal fees Other Accrued Liabilities Current Other Debt Instrument [Table] Schedule of Long-term Debt Instruments [Table] Debt Instrument [Axis] Debt Instrument Name [Domain] Debt Instrument, Name [Domain] Covenant Requirement [Member] Covenant Requirement [Member] Cash Required Under Debt Covenants [Member] Period 2 [Member] Period Two [Member] Quarterly Payment During 2015 [Member] Period 3 [Member] Period Three [Member] Quarterly Payment During 2016 and Later [Member] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent Events [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Percentage Of Net Product Sales Used To Pay Obligation Percentage Of Net Product Sales Used To Pay Obligation Payment obligation based on a percentage of net product sales Debt Instrument Periodic Payment Quarterly payment amount cap Debt Instrument, Fee, Percentage Debt Instrument Fee Percentage Percentage of payments received for upfront, milestone or other contingent fees Debt Instrument Increase Decrease For Period Description Increase in percentage used to calculate long term payment obligations, description Debt Instrument Restrictive Covenants Debt covenant, description Interest expense on long-term obligation Long Term Debt Long term debt carrying value Deferred Finance Costs Net Issuance costs capitalized Unamortized Debt Issuance Expense Unamortized issuance cost Debt Instrument Carrying Amount Total repayment obligation Debt Instrument Unamortized Discount Premium Net Less interest to be accreted in future periods Debt instrument, payment to date. Debt instrument, payment to date Less payments made Schedule of Operating Leased Assets [Table] Operating Leased Assets [Line Items] Operating Leases Future Minimum Payments Due Minimum rental payment for lease Lessee Leasing Arrangements, Operating Leases, Term of Contract Term of leases Lease And Rental Expense Rent expenses Schedule Of Stock By Class [Table] Shareholders Equity Related Party Transactions By Related Party [Axis] Related Party [Domain] Related Party [Domain] Related Parties [Member] Related Parties [Member] Related Parties [Member] Class Of Warrant Or Right [Axis] Class Of Warrant Or Right [Domain] Class of Warrant or Right [Domain] Warrant [Member] Warrants [Member] April Twenty Ten Private Placement [Member] April Twenty Ten Private Placement [Member] April 2010 Private Placement [Member] April Twenty Ten and March Twenty Twelve Private Placement [Member] April Twenty Ten And March Twenty Twelve Private Placement [Member] April 2010 and March 2012 Private Placements [Member] March Twenty Twelve Private Placement [Member] March Twenty Twelve Private Placement [Member] March 2012 Private Placement [Member] Private Placement [Member] Private Placement [Member] Share Based Goods And Nonemployee Services Transaction By Supplier [Axis] Share Based Goods And Nonemployee Services Transaction Supplier [Domain] Share-based Goods and Nonemployee Services Transaction, Supplier [Domain] Performance Based Option [Member] Performance Based Option [Member] Performance Based Option [Member] Title Of Individual [Axis] Title Of Individual With Relationship To Entity [Domain] Relationship to Entity [Domain] Employee And Director Stock Option [Member] Employee And Director Stock Option [Member] Employee And Director Stock Option [Member] Plan Name [Axis] Plan Name [Domain] Plan Name [Domain] Stock Options Fiscal 2004 Plan [Member] Stock Options Fiscal Twenty Zero Four Plan [Member] 2004 Equity Incentive Plan [Member] Stock Option Plan 2012 [Member] Stock Option Plan Twenty Twelve [Member] 2012 Stock Option Plan [Member] Stock Options Fiscal 2012 Plan [Member] Stock Options Fiscal Twenty Twelve Plan [Member] 2012 Equity Incentive Award Plan [Member] Class Of Stock [Line Items] Shareholders Equity [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised Warrant exercised on a cashless net-exercise basis Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercise Price Exercise price of warrants Proceeds From Warrant Exercises and Warrant Issuance Proceeds From Warrant Exercises And Warrant Issuance Proceeds from warrant exercises and issuance of new warrants Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Warrants issued and outstanding Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable Latest date warrants can be exercised Percentage of securities sold to related parties. Securities Sold Percentage Percentage of securities sold to related parties Share Price Common stock, price per share Proceeds From Issuance Of Common Stock Net sales from sale of common stock Proceeds From Warrant Exercises Proceeds from warrant exercises Stock And Warrants Issued During Period Shares New Issues Stock And Warrants Issued During Period Shares New Issues Stock and warrants issued during period Liquidated Damages Liquidated Damages Liquidated damages to other non-operating expense Liquidated Damage As Percentage Of Amount Invested By Investors Liquidated Damage As Percentage Of Amount Invested By Investors Percentage of liquidated damages Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized Increase in shares authorized for grant Number of additional shares authorized for issuance Increase in Shares Available for Issuance Percentage Increase In Shares Available For Issuance Percentage Increase in shares available for issuance based on percentage of common stock outstanding Number of Stock Option Plans Number Of Stock Option Plans Number of stock option plans Number of award. Number of awards outstanding Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number Options Exercisable, Number of Shares Number of shares issuable Options exercisable Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent Exercise price as percentage of fair value of common stock Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period 1 Stock options, vesting period Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Ending balance Beginning balance Shares available for future grants Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value Total intrinsic value of options exercised Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value 1 Fair value of options vested Forfeiture Rate For Options Granted To Employees Forfeiture Rate For Options Granted To Employees Forfeiture rate, stock option expense Allocated Share Based Compensation Expense Non-cash stock-based compensation expense Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Unrecognized compensation expense Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition 1 Unrecognized compensation expense, weighted-average vesting period Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Unvested shares Award Type [Axis] Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain] Equity Award [Domain] Stock Option [Member] Stock Options [Member] Available For Future Grant Under Equity Plans [Member] Available For Future Grant Under Equity Plans [Member] Shares Available for Grant Under Stock Option Plans [Member] Common Stock Capital Shares Reserved For Future Issuance Shares of common stock reserved for future issuance Schedule Of Employee Stock Ownership Plan E S O P Disclosures [Table] Schedule of Employee Stock Ownership Plan (ESOP) Disclosures [Table] Stock Option Plan 2000 [Member] Stock Option Plan Two Thousand [Member] 2000 Stock Option Plan [Member] Stock options 2004 and 2012 plans [Member] Stock Options Two Thousand Four And Two Thousand Twelve Plans [Member] 2004 and 2012 Plans [Member] Employee Stock Ownership Plan E S O P Disclosures [Line Items] Employee Stock Ownership Plan (ESOP) Disclosures [Line Items] Share Based Compensation Arrangement By Share Based Payment Award Additional General Disclosures [Abstract] Shares Available For Future Grant Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Shares granted Shares granted Share-based Compensation Arrangement by Share-based Payment Award, Options Available for Grant, Expirations in Period Sharebased Compensation Arrangement By Sharebased Payment Award Options Available For Grant Expirations In Period Shares expired Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Number Of Shares Available Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Number Of Shares Available Shares cancelled and forfeited Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding [Roll Forward] Shares Subject to Options Outstanding Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Ending balance Beginning balance Options Outstanding, Number of Shares Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period Shares expired Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Shares cancelled and forfeited Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number Options fully vested and expected to vest Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Rollforward Outstanding Options, Weighted- Average Exercise Price Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Ending balance Beginning balance Options Outstanding, Weighted Average Exercise Price Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price Shares granted Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price Shares exercised Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price Shares expired Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price Shares cancelled and forfeited Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Options exercisable Options Exercisable, Weighted Average Exercise Price Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price Options fully vested and expected to vest Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract] Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract] Outstanding Options, Weighted Average Remaining Contractual Life Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term 2 Options Outstanding, Weighted Average Remaining Contractual Life (in years) Weighted average remaining contractual life Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term 1 Weighted average remaining contractual life, Options exercisable Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term 1 Weighted average remaining contractual life, Options fully vested and expected to vest Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract] Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract] Outstanding Options, Aggregate Intrinsic Value Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Aggregate Intrinsic Value Options Outstanding, Aggregate Intrinsic Value Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value 1 Options exercisable Options Exercisable, Aggregate Intrinsic Value Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value Options fully vested and expected to vest Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Table] Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table] Price Range One [Member] Price Range One [Member] $0.96 - $ 2.00 [Member] Price Range Two [Member] Price Range Two [Member] $2.01 - $ 3.00 [Member] Price Range Three [Member] Price Range Three [Member] $3.01 - $ 4.50 [Member] Price Range Four [Member] Price Range Four [Member] $4.51 - $ 5.70 [Member] Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Exercise Price Of Options, minimum Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Exercise Price Of Options, Maximum Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions And Methodology [Abstract] Weighted-average assumptions for stock options granted: Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Risk-free interest rate Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term 1 Expected term Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Expected volatility of stock price Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Dividend rate Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value Weighted average grant date fair value-based measurement Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Research And Development Expense [Member] Research and Development Expense [Member] Selling General And Administrative Expenses [Member] Selling, General and Administrative Expense [Member] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Class Of Warrant Or Right [Table] Class of Warrant or Right [Table] Warrant 1 [Member] Warrant One [Member] March 2008 Financing [Member] Warrant 2 [Member] Warrant Two [Member] March 2012 Warrant Exchange [Member] Class Of Warrant Or Right [Line Items] Class of Warrant or Right [Line Items] Warrants And Rights Outstanding Number of shares Investment Warrants Expiration Date Expiration Date Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis] Antidilutive Securities Name [Domain] Antidilutive Securities, Name [Domain] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount Securities outstanding that could potentially dilute per share data Income Taxes [Table] Income Taxes [Table] Income Taxes [Table] Tax Credit Carryforward [Axis] Tax Credit Carryforward Name [Domain] Tax Credit Carryforward, Name [Domain] Research [Member] Research Tax Credit Carryforward [Member] Income Tax Authority [Axis] Income Tax Authority [Domain] Income Tax Authority [Domain] Internal Revenue Service I R S [Member] Federal [Member] State And Local Jurisdiction [Member] California State [Member] Other States [Member] Other States [Member] Other States [Member] Income Taxes [Line Items] Income Taxes [Line Items] Income Taxes [Line Items] Valuation Allowance Deferred Tax Asset Change In Amount Increase in valuation allowance Operating Loss Carryforwards Net operating loss carryforwards Operating Loss Carryforwards, Expiration Year Operating Loss Carryforwards Expiration Year Net operating loss carryforwards, expiration year Tax Credit Carryforward Amount Research and development tax credits Tax Credit Carryforward, Expiration Year Tax Credit Carryforward Expiration Year Research and development tax credit, expiration year Deferred Tax Assets Net [Abstract] Deferred tax assets: Deferred Tax Assets Operating Loss Carryforwards Federal and state net operating losses Deferred Tax Assets Deferred Expense Capitalized Research And Development Costs Deferred Tax Assets Deferred Expense Capitalized Research And Development Costs Capitalized research and patent costs Deferred Tax Assets Tax Credit Carryforwards Research Research credits Deferred Tax Assets Financing Obligation Deferred Tax Assets Financing Obligation Biopharma Financing Agreement Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Stock-based compensation costs Deferred Tax Assets Other Other Deferred Tax Assets Gross Total deferred tax assets Deferred Tax Assets Valuation Allowance Valuation allowance Deferred Tax Assets Net Net deferred tax assets Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate U.S. federal taxes (benefit) at statutory rate Income Tax Reconciliation Unutilized Net Operating Losses Income Tax Reconciliation Unutilized Net Operating Losses Unutilized, net operating loss Unutilized research credits Income Tax Reconciliation Nondeductible Expense Research And Development Non-deductible offset of Orphan Drug Credit Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost Non-deductible stock based compensation Income Tax Reconciliation Nondeductible Expense Other Other Income Tax Expense Benefit Total Loss Contingency Accrual At Carrying Value Losses for contingent liability Gross Profit Gross profit on product sales Building [Member] Office Space [Member] Automobiles [Member] Automobiles [Member]